Ginsenoside Rg3 Serves as an Adjuvant Chemotherapeutic Agent and VEGF Inhibitor in the Treatment of Non-Small Cell Lung Cancer: A Meta-Analysis and Systematic Review

Table 4

Publication bias.

Egger’s publication test	value
Response rate	0.035
Disease control rate	0.455
KPS	0.046
Decline of leucocyte count	0.448
Anemia	0.182
Decline of platelet count	0.029
Nausea and vomiting	0.159
Hepatic dysfunction	0.023
Alopecia	0.285
Overall survival	0.083